Newsfeeds - Spark Newswire

4 minute read

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay

Today, 5:54 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20)

ABCL

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 5:54 AM

AFIB

1 minute read

Canaccord Genuity Upgrades Acutus Medical to Buy, Raises Price Target to $18

By Benzinga Newsdesk

Today, 5:54 AM

Canaccord Genuity analyst William Plovanic upgrades Acutus Medical (NASDAQ:AFIB) from Hold to Buy and raises the price target from $11 to $18.

AFIB

1 minute read

FDA
News

Acutus Medical National Institutes Of Health ClinicalTrials.gov Study Record Detail For Co.’s ‘AcQBlate Force Sensing Ablation System Study for Atrial Fibrillation (AcQForce AF-EU)’

By Benzinga Newsdesk

Today, 5:54 AM

https://clinicaltrials.gov/ct2/show/NCT04941391

AFIB

7 minute read

Uncategorized

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

By Shanthi Rexaline

Today, 5:54 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)

ABIO

9 minute read

Uncategorized

Earnings Scheduled For May 12, 2021

By Benzinga Insights

Today, 5:54 AM

Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.

ADMA

6 minute read

Uncategorized

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

By Shanthi Rexaline

Today, 5:54 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)

ABBV

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 5:54 AM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL